🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/04/1997 | 39,42 | 39,78 | 39,00 | 39,00 | -2,24% | 1,97% | 6.808.646 |
| 10/04/1997 | 39,24 | 40,08 | 39,18 | 39,90 | +2,61% | 2,28% | 10.913.034 |
| 09/04/1997 | 39,12 | 39,24 | 38,35 | 38,88 | -4,40% | 2,29% | 21.814.749 |
| 08/04/1997 | 41,33 | 41,33 | 39,84 | 40,67 | -1,59% | 3,61% | 5.764.210 |
| 07/04/1997 | 41,98 | 42,04 | 41,27 | 41,33 | -0,29% | 1,85% | 4.384.622 |
| 04/04/1997 | 40,37 | 41,69 | 40,26 | 41,45 | +1,91% | 3,55% | 6.600.094 |
| 03/04/1997 | 40,08 | 40,73 | 39,96 | 40,67 | -0,15% | 1,93% | 6.376.870 |
| 02/04/1997 | 41,27 | 41,39 | 40,49 | 40,73 | -1,44% | 2,17% | 5.134.362 |
| 01/04/1997 | 40,08 | 41,45 | 39,90 | 41,33 | +2,82% | 3,87% | 9.848.266 |
| 31/03/1997 | 42,16 | 42,22 | 39,54 | 40,20 | -5,20% | 6,36% | 10.961.870 |
| 27/03/1997 | 43,36 | 43,54 | 41,57 | 42,40 | -2,20% | 4,54% | 6.247.966 |
| 26/03/1997 | 43,54 | 44,07 | 43,24 | 43,36 | -0,14% | 1,92% | 4.747.021 |
| 25/03/1997 | 42,94 | 43,95 | 42,76 | 43,42 | +1,25% | 2,78% | 6.870.269 |
| 24/03/1997 | 43,54 | 43,65 | 42,04 | 42,88 | -1,37% | 3,70% | 7.326.358 |
| 21/03/1997 | 43,42 | 44,19 | 42,94 | 43,48 | +0,41% | 2,88% | 8.786.642 |
| 20/03/1997 | 43,59 | 43,71 | 43,06 | 43,30 | -0,82% | 1,50% | 5.254.253 |
| 19/03/1997 | 43,18 | 43,83 | 42,64 | 43,65 | +1,24% | 2,76% | 6.582.069 |
| 18/03/1997 | 43,83 | 43,89 | 42,88 | 43,12 | -0,82% | 2,31% | 5.616.651 |
| 17/03/1997 | 42,22 | 43,54 | 42,16 | 43,48 | +3,11% | 3,25% | 9.014.896 |
| 14/03/1997 | 43,18 | 43,30 | 41,63 | 42,16 | -2,35% | 3,87% | 10.417.120 |
| 13/03/1997 | 43,54 | 44,01 | 43,06 | 43,18 | -1,90% | 2,19% | 5.238.952 |
| 12/03/1997 | 44,43 | 44,61 | 43,65 | 44,01 | -1,73% | 2,15% | 3.958.925 |
| 11/03/1997 | 45,50 | 45,50 | 44,67 | 44,79 | -1,57% | 1,83% | 3.976.112 |
| 10/03/1997 | 44,79 | 45,56 | 44,61 | 45,50 | +2,55% | 2,13% | 5.720.403 |
| 07/03/1997 | 44,01 | 44,91 | 43,71 | 44,37 | +0,81% | 2,71% | 7.589.197 |
| 06/03/1997 | 44,85 | 44,85 | 43,89 | 44,01 | -1,86% | 2,13% | 5.380.432 |
| 05/03/1997 | 43,65 | 44,91 | 43,54 | 44,85 | +3,01% | 3,14% | 6.519.189 |
| 04/03/1997 | 44,85 | 44,91 | 43,00 | 43,54 | -2,93% | 4,26% | 6.082.382 |
| 03/03/1997 | 43,24 | 44,91 | 43,24 | 44,85 | +2,04% | 3,86% | 5.721.242 |
| 28/02/1997 | 44,01 | 44,49 | 43,42 | 43,95 | -1,86% | 2,44% | 8.489.219 |